Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2011

01.01.2011 | Retinal Disorders

Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema

verfasst von: Takanori Kameda, Kazuaki Nishijima, Noriyuki Unoki, Atsushi Sakamoto, Hisako Hayashi, Hideyasu Oh, Mihori Kita, Nagahisa Yoshimura

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the geographic pattern of central retinal sensitivity and its resolution shortly after intravitreal injection of triamcinolone acetonide (IVTA) for diabetic macular edema (DME).

Methods

Twenty eyes of 20 patients who underwent IVTA for the treatment of DME were reviewed retrospectively. Early changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), photoreceptor inner and outer segments (IS/OS) line and central retinal sensitivity were analyzed. Retinal sensitivity was measured at 40 points within the central 10 degrees of the macula with the Micro Perimeter 1 before treatment, and at 1 week and 1 month after IVTA.

Results

Mean BCVA and CMT improved significantly at 1 week and 1 month after IVTA. Mean retinal sensitivity, however, showed no significant improvement at 1 week (P = 0.238), but did show significant improvement at 1 month (P = 0.0003). Mean retinal sensitivity of the points at the central 2 degrees, which was significantly lower than that at 6 and 10 degrees before treatment, showed improvement similar to those of 6 and 10 degrees after IVTA. Mean retinal sensitivity in the nasal quadrant of the macular area had the best sensitivity at all time points, and improved more than it did in the other quadrants. Mean retinal sensitivity in the central 2 degrees was better in the eyes with complete IS/OS line (P < 0.0001).

Conclusions

BCVA and CMT improved significantly after IVTA for DME. Retinal sensitivity also showed significant, albeit relatively slow, improvement. The nasal quadrant of the macular area showed more improvement than did any other quadrant.
Literatur
1.
Zurück zum Zitat Early Treatment Diabetic Retinopathy Study Research Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 94:761–774 Early Treatment Diabetic Retinopathy Study Research Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 94:761–774
2.
Zurück zum Zitat Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29:2–6CrossRefPubMed Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29:2–6CrossRefPubMed
3.
Zurück zum Zitat Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765–772CrossRefPubMed Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765–772CrossRefPubMed
4.
Zurück zum Zitat Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA (2004) Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 122:1131–1136CrossRefPubMed Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA (2004) Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 122:1131–1136CrossRefPubMed
5.
Zurück zum Zitat Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS, Noureddin BN (2004) Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 122:1137–1140CrossRefPubMed Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS, Noureddin BN (2004) Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 122:1137–1140CrossRefPubMed
6.
Zurück zum Zitat Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136:384–386CrossRefPubMed Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136:384–386CrossRefPubMed
7.
Zurück zum Zitat Conway MD, Canakis C, Livir-Rallatos C, Peyman GA (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29:27–33CrossRefPubMed Conway MD, Canakis C, Livir-Rallatos C, Peyman GA (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29:27–33CrossRefPubMed
8.
Zurück zum Zitat Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135:246–249CrossRefPubMed Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135:246–249CrossRefPubMed
9.
Zurück zum Zitat Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533–1538CrossRefPubMed Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533–1538CrossRefPubMed
10.
Zurück zum Zitat Sutter FK, Simpson JM, Gillies MC (2004) Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111:2044–2049CrossRefPubMed Sutter FK, Simpson JM, Gillies MC (2004) Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111:2044–2049CrossRefPubMed
11.
Zurück zum Zitat Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136CrossRefPubMed Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S (2004) Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88:1131–1136CrossRefPubMed
12.
Zurück zum Zitat Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927CrossRefPubMed Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927CrossRefPubMed
13.
Zurück zum Zitat Bardak Y, Cekic O, Sahin Tig U, Bardak H (2007) Alterations in central retinal sensitivity after intravitreal triamcinolone injection for diffuse diabetic macular edema. Eur J Ophthalmol 17:780–784PubMed Bardak Y, Cekic O, Sahin Tig U, Bardak H (2007) Alterations in central retinal sensitivity after intravitreal triamcinolone injection for diffuse diabetic macular edema. Eur J Ophthalmol 17:780–784PubMed
14.
Zurück zum Zitat Grenga P, Lupo S, Domanico D, Vingolo EM (2008) Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Retina 28:1270–1275CrossRefPubMed Grenga P, Lupo S, Domanico D, Vingolo EM (2008) Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study. Retina 28:1270–1275CrossRefPubMed
15.
Zurück zum Zitat Karacorlu M, Ozdemir H, Senturk F, Arf Karacorlu S, Uysal O (2008) Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection. Eur J Ophthalmol 18:601–608PubMed Karacorlu M, Ozdemir H, Senturk F, Arf Karacorlu S, Uysal O (2008) Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection. Eur J Ophthalmol 18:601–608PubMed
16.
Zurück zum Zitat Ozkiris A, Evereklioglu C, Oner A, Erkilic K (2004) Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema. Doc Ophthalmol 109:139–145CrossRefPubMed Ozkiris A, Evereklioglu C, Oner A, Erkilic K (2004) Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema. Doc Ophthalmol 109:139–145CrossRefPubMed
17.
Zurück zum Zitat Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425–427CrossRefPubMed Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425–427CrossRefPubMed
18.
Zurück zum Zitat Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61CrossRefPubMed Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61CrossRefPubMed
19.
Zurück zum Zitat Diabetic Retinopathy Clinical Research Network (DRCR.net) (2009) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 127:245–251CrossRef Diabetic Retinopathy Clinical Research Network (DRCR.net) (2009) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 127:245–251CrossRef
20.
Zurück zum Zitat Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301PubMed Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301PubMed
21.
Zurück zum Zitat Uckermann O, Kutzera F, Wolf A, Pannicke T, Reichenbach A, Wiedemann P, Wolf S, Bringmann A (2005) The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 315:1036–1045CrossRefPubMed Uckermann O, Kutzera F, Wolf A, Pannicke T, Reichenbach A, Wiedemann P, Wolf S, Bringmann A (2005) The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 315:1036–1045CrossRefPubMed
22.
Zurück zum Zitat Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC (2008) Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 57:1026–1033CrossRefPubMed Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC (2008) Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 57:1026–1033CrossRefPubMed
23.
Zurück zum Zitat Wolf S, Arend O, Schulte K, Ittel TH, Reim M (1994) Quantification of retinal capillary density and flow velocity in patients with essential hypertension. Hypertension 23:464–467PubMed Wolf S, Arend O, Schulte K, Ittel TH, Reim M (1994) Quantification of retinal capillary density and flow velocity in patients with essential hypertension. Hypertension 23:464–467PubMed
24.
Zurück zum Zitat Unoki N, Nishijima K, Sakamoto A, Kita M, Watanabe D, Hangai M, Kimura T, Kawagoe N, Ohta M, Yoshimura N (2007) Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Am J Ophthalmol 144:755–760CrossRefPubMed Unoki N, Nishijima K, Sakamoto A, Kita M, Watanabe D, Hangai M, Kimura T, Kawagoe N, Ohta M, Yoshimura N (2007) Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Am J Ophthalmol 144:755–760CrossRefPubMed
Metadaten
Titel
Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema
verfasst von
Takanori Kameda
Kazuaki Nishijima
Noriyuki Unoki
Atsushi Sakamoto
Hisako Hayashi
Hideyasu Oh
Mihori Kita
Nagahisa Yoshimura
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2011
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1447-1

Weitere Artikel der Ausgabe 1/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.